Literature DB >> 11189

Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

C C Shepard, R Van Landingham, L L Walker.   

Abstract

Infections of mice with Mycobacterium leprae in one rear foot pad immunized them against a second infection in the other rear foot pad. Purified bacilli harvested from the first infection also produced immuniy when injection into the foot pads of previously uninfected mice. Injections of BCG afforded similar protection, but had no adjuvant effect on M. leprae. M. duvali, a cultivable mycobacterium that is reported to be more closely related antigenically to M. leprae than BCG is, provided much less protection against M. leprae challenge than BCG did. Moreover, when M. duvali was mixed with BCG, it was not any more effective than BCG alone. Graft-versus-host reactions, induced by injections of parental spleen cells into F1 hybrids, provided no protection against M. tuberculosis and M. marinum challenge. They gave moderate protection against M. leprae in one experiment but not in another with a different schedule. Allogenic spleen cells had a protective effect when injected locally into the infected foot pad. The effect produced by these injections of spleen cells was a delay in the appearance of bacterial growth; however, there was no decrease in the rate of logarithmic growth when it did appear and no reduction in the eventual plateau level.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 11189      PMCID: PMC415472          DOI: 10.1128/iai.14.4.919-928.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE.

Authors:  C C SHEPARD
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

2.  Enhancement of resistance to murine leprosy by BCG plus specific antigen.

Authors:  J M FERNANDEZ; J H HANKS
Journal:  Int J Lepr       Date:  1956 Jan-Mar

3.  Vaccination of mice against M. leprae infection.

Authors:  C C Shepard
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

4.  Superinfection in mice previously infected with Mycobacterium leprae.

Authors:  L Levy
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

5.  IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.

Authors:  C C SHEPARD; R S GUINTO
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

6.  Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.

Authors:  L Levy; H Ng; M J Evans; J L Krahenbuhl
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

7.  Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J L Krahenbuhl; L Levy; J S Remington
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

8.  Hereditary Characteristic that Varies Among Isolates of Mycobacterium leprae.

Authors:  C C Shepard; D H McRae
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

9.  MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE.

Authors:  C C SHEPARD; D H MCRAE
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

10.  Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.

Authors:  R K Gershon; P W Askenase; M D Gershon
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  16 in total

1.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.

Authors:  R H Gelber; P J Brennan; S W Hunter; M W Munn; J M Monson; L P Murray; P Siu; M Tsang; E G Engleman; N Mohagheghpour
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.

Authors:  J L Krahenbuhl; R C Humphres; P C Henika
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

4.  Effect of levamisole on Mycobacterium leprae in mice.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  Induction of cell-mediated immunity to Mycobacterium leprae in guinea pigs.

Authors:  V Mehra; B R Bloom
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Specific and nonspecific resistance in mice immunized with irradiated Myobacterium leprae.

Authors:  P J Patel; M J Lefford
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

7.  Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge.

Authors:  C C Shepard; L L Walker; R M Van Landingham
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Lack of protection afforded by ribonucleic acid preparations from Mycobacterium tuberculosis against Mycobacterium leprae infections in mice.

Authors:  C C Shepard; A Y Youmans; G P Youmans
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Heat stability of Mycobacterium leprae immunogenicity.

Authors:  C C Shepard; L L Walker; R van Landingham
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Searches among mycobacterial cultures for antileprosy vaccines.

Authors:  C C Shepard; R van Landingham; L L Walker
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.